<DOC>
	<DOC>NCT01849458</DOC>
	<brief_summary>The aim of this study is to collect and report data from a consecutive series of patients implanted with these products as part of a post-market surveillance plan for CE Mark approval in the European Union.</brief_summary>
	<brief_title>BioFiber Scaffold Post-Market Observational Study</brief_title>
	<detailed_description />
	<criteria>Patients 18 years of age or older Patients with full thickness rotator cuff tears (confirmed at time of surgery) that are eligible for rotator cuff repair. Patients willing and able to comply with the requirements of the study protocol and provide informed consent. Patients with active or latent infection Patients with decreased vascularity Patients with pathological soft tissue conditions Patients with a known allergy or sensitivity to tetracycline hydrochloride or kanamycin sulfate Patients with a known allergy or sensitivity to bovine collagen (BioFiberCM only) Participating in a concurrent study that has not been approved for concurrent enrollment by the Clinical Study Manager</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>